- Investing Ideas
- Global Pharmaceuticals & Biotech Breakout Stocks
Global Pharmaceuticals & Biotech Breakout Stocks
Results
23
Stocks where the price continues to rise after more than a year of consistent gains.
23 companies
AtaiBeckley
Market Cap: US$2.7b
A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of mental health treatments in the United States, Germany, and Canada.
ATAI
US$7.19
7D
44.7%
1Y
103.7%
Iovance Biotherapeutics
Market Cap: US$2.2b
A commercial-stage biopharmaceutical company, develops and commercializes cell therapies using autologous tumor infiltrating lymphocyte for the treatment of metastatic melanoma and other solid tumor cancers in the United States and internationally.
IOVA
US$5.02
7D
24.3%
1Y
101.6%
CareDx
Market Cap: US$2.1b
Provides solutions for improving outcomes for transplant patients and advancing organ health in the United States and internationally.
CDNA
US$38.37
7D
33.4%
1Y
200.9%
Harbin Pharmaceutical Group
Market Cap: CN¥13.4b
Engages in the research, development, manufacture, wholesale, and retail of pharmaceuticals in China and internationally.
600664
CN¥5.31
7D
43.1%
1Y
32.8%
Xencor
Market Cap: US$1.3b
A clinical-stage biopharmaceutical company, focuses on the discovery and development of engineered antibodies for the treatment of cancer and autoimmune diseases.
XNCR
US$18.81
7D
25.7%
1Y
106.7%
Gansu Longshenrongfa Pharmaceutical IndustryLTD
Market Cap: CN¥3.7b
Researches, develops, produces, and sells traditional Chinese medicines, medical devices, and health products in China and internationally.
300534
CN¥12.04
7D
33.8%
1Y
16.3%
Valerio Therapeutics Société anonyme
Market Cap: €414.5m
A clinical-stage biotechnology company, develops technology platforms dedicated to the targeted delivery of therapies.
ALVIO
€0.83
7D
107.5%
1Y
1,409.1%
EI- Nile for Pharmaceuticals and Chemical Industries
Market Cap: ج.م11.7b
Develops, produces, and sells pharmaceutical products in Egypt.
NIPH
ج.م234.99
7D
33.4%
1Y
279.1%
GlaxoSmithKlineE
Market Cap: ج.م9.9b
Engages in production of pharmaceutical chemicals.
BIOC
ج.م118.00
7D
57.8%
1Y
167.4%
Great Novel Therapeutics Biotech & Medicals
Market Cap: NT$3.3b
Engages in the development of drugs for the treatment of advanced and refractory cancers in Taiwan.
7427
NT$78.30
7D
56.3%
1Y
108.8%
Entera Bio
Market Cap: US$97.6m
A clinical stage company, engages in the development of oral peptides and protein replacement therapies in Israel and internationally.
ENTX
US$1.99
7D
21.3%
1Y
0.04%
New Green Hemp
Market Cap: US$48.5m
New Green Hemp Inc. cultivates and sells hemp products.
NGHI
US$1.92
7D
28.9%
1Y
175.4%
Apollomics
Market Cap: US$40.7m
A clinical-stage biopharmaceutical company, engages in the discovery and development of oncology therapies to harness the immune system and target specific molecular pathways to inhibit cancer.
APLM
US$18.86
7D
32.7%
1Y
166.8%
Zhengye Biotechnology Holding
Market Cap: US$33.1m
Engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in the People’s Republic of China.
ZYBT
US$8.01
7D
1,035.8%
1Y
40.8%
Numinus Wellness
Market Cap: US$12.5m
Provides psychedelic-assisted therapy training, lab testing, and psychotherapy services in Canada and the United States.
NUMI.F
US$0.048
7D
37.9%
1Y
104.3%
Stem Cells Spin
Market Cap: zł22.3m
Operates as a biotechnology company in Poland.
SCS
zł0.54
7D
44.4%
1Y
76.5%
Blueberries Medical
Market Cap: CA$7.4m
A consumer science company, engages in the commercialization of medicinal cannabis and related products in Colombia.
BBM
CA$0.015
7D
50.0%
1Y
50.0%
BPH Global
Market Cap: AU$4.7m
Engages in sourcing, producing, marketing, and selling traditional medicines in Australia, Singapore, China, and Southeast Asia.
BP8
AU$0.002
7D
33.3%
1Y
0%
Innovation Pharmaceuticals
Market Cap: US$1.6m
A clinical stage biopharmaceutical company, develops small molecule therapies to treat inflammatory diseases, cancer, dermatology, and anti- infective.
IPIX
US$0.002
7D
566.7%
1Y
566.7%
International Stem Cell
Market Cap: US$1.4m
A clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in the United States, Asia, Europe, and internationally.
ISCO
US$0.20
7D
20.2%
1Y
31.6%
NAVCO Pharmaceuticals
Market Cap: CA$285.3k
Develops and commercializes supplemental and therapeutic consumer health and wellness products in the areas of antibacterial and immunity support and infectious disease prevention in Canada.
NAV
CA$0.01
7D
100.0%
1Y
100.0%
Pressure BioSciences
Market Cap: US$8.6k
Develops and sells high pressure technology-based instruments, consumables, and services for life sciences and other industries worldwide.
PBIO
US$0.0047
7D
571.4%
1Y
1,075.0%
OWC Pharmaceutical Research
Market Cap: US$5.0k
Through its subsidiary, One World Cannabis Ltd., engages in the research and development of cannabis-based medical products.
OWCP
US$0.00001
7D
900.0%
1Y
900.0%